Date: 2014-03-24
Type of information: Company acquisition
Acquired company: Bionamics (Germany)
Acquiring company: Evotec (Germany)
Amount: undisclosed
Terms: * On March 24, 2014, Evotec announced the acquisition of the Germany-based Bionamics GmbH. Bionamics is an asset management company that focuses on the translation of academic innovations into attractive assets for the biotech and Pharma industry. The transaction comprises the acquisition of all shares of Bionamics against cash and future milestone payments. Next to an experienced management team Bionamics brings a portfolio of highly attractive and fully funded projects especially in neurodegeneration and CNS to Evotec. Further financial details of the transaction remain undisclosed.
Details: Bionamics GmbH is an asset management company in Hamburg, Germany, bridging the gap between excellent research projects and the industry\'s need for pre-clinical and clinical development programmes. The company was founded in 2006 and currently employs three employees. Bionamics has set up and manages NEU² (www.neu-quadrat.de), a consortium established to generate new treatment options in neurodegenerative diseases and supported by public funds of up to € 40 million. Before founding Bionamics Timm Jessen was the CSO of Evotec AG from 1997 to 2004.
Related: Technology - Services CRO
